Ribonucleotide Reductase Inhibitor 3-AP Induces Oncogenic Virus Infected Cell Death and Represses Tumor Growth
Open Access
- 1 January 2018
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 9 (23) , 4503-4509
Abstract
Kaposi's Sarcoma-associated Herpesvirus (KSHV) is the etiologic agent of several human malignancies, particularly Kaposi's Sarcoma (KS), which preferentially arise in immunocompromised patients such as HIV+ subpopulation while still lacking of effective therapeutic options. We recently found that the ribonucleotide reductase (RR) subunit M2 is potentially regulated by the key oncogenic HGF/c-MET pathway in KSHV-related lymphoma cells. One of RR inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) effectively induced apoptosis of KSHV+ lymphomas and suppressed tumor progression in vivo. In the current study, we found that 3-AP treatment selectively inhibited the proliferation of KSHV-infected endothelial cells, the major cellular components of KS, through inducing DNA damage, reducing the levels of intracellular iron and reactive oxygen species (ROS) and increasing viral lytic gene expression. By using a KS-like nude mouse model, we found that 3-AP treatment significantly suppressed KSHV induced tumorigenesis in vivo. Taken together, our data demonstrate targeting RR by 3-AP may represent a promising strategy for improving the treatment of KS in future.Keywords
This publication has 24 references indexed in Scilit:
- Immune reconstitution inflammatory syndrome associated with Kaposi sarcomaAIDS, 2013
- Clinical characteristics and outcomes of HIV‐infected children diagnosed with kaposi sarcoma in malawi and botswanaPediatric Blood & Cancer, 2013
- The Role of PPARγinHelicobacter pyloriInfection and Gastric CarcinogenesisPPAR Research, 2012
- Oxidative Stress Induces Reactivation of Kaposi's Sarcoma-Associated Herpesvirus and Death of Primary Effusion Lymphoma CellsJournal of Virology, 2011
- Inhibition of Iron Uptake Is Responsible for Differential Sensitivity to V-ATPase Inhibitors in Several Cancer Cell LinesPLOS ONE, 2010
- Long-Term-Infected Telomerase-Immortalized Endothelial Cells: a Model for Kaposi's Sarcoma-Associated Herpesvirus Latency In Vitro and In VivoJournal of Virology, 2006
- NOX enzymes and the biology of reactive oxygenNature Reviews Immunology, 2004
- Modulation of Cellular and Viral Gene Expression by the Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated HerpesvirusJournal of Virology, 2001
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Endemic Kaposi's sarcoma in Africa and local volcanic soilsThe Lancet, 1993